Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Electronic cigarettes with nicotine versus varenicline versus nicotine-free electronic cigarettes for smoking cessation
2017-003588-37Phase 3Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of varenicline in nicotine dependence (3 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Continuous smoking abstinence rate. Started Sep 2020; status: active.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on 2017-003588-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003588-37.